1
|
Rehman S, Harikrishna A, Silwal A, Sumie BR, Mohamed S, Kolhe N, Maddi M, Huynh L, Gutierrez J, Annepu YR, Farrukh AM. Ovarian angiosarcoma: A systematic review of literature and survival analysis. Ann Diagn Pathol 2024; 73:152331. [PMID: 38811255 DOI: 10.1016/j.anndiagpath.2024.152331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2024] [Accepted: 05/14/2024] [Indexed: 05/31/2024]
Abstract
Ovarian angiosarcoma (OA) is rare, with only sporadic cases reported in English literature. We performed a systematic review of cases published in the PubMed, Science Direct, and Google Scholar databases with the aim of describing the reported clinicopathological features of OA. Fifty-three articles that reported 60 patients were reviewed. Of the 60 patients, 7 (11.6 %) were diagnosed with secondary (metastatic) ovarian angiosarcoma and 53 (88.3 %) were diagnosed with primary ovarian angiosarcoma. The mean age at presentation for ovarian angiosarcoma was 38.3±17.8 years. The average tumor size for ovarian angiosarcoma was 11.9±6.1 cm. Abdominal distention was reported in 45/60 (75 %). Microscopic examination revealed necrosis in 28/60 (46.7 %), pleomorphism in 32/59 (54.2 %), mitotic figures in 44/60 (73.3 %), spindle-shaped cells in 27/36 (75 %), epithelioid-shaped cells in 20/36 (55.5 %), and mixed epithelioid and spindle-shaped cells in 12/36 (33.3 %) patients. On immunohistochemistry CD 31 was positive in 41/41 (100 %), CD 34 in 38/39 (97.4 %), and Factor VIII related antigen in 18/21 (85.7 %) patients. Metastasis was present in 43/60 (71.6 %) patients. Chemotherapy and surgery was performed in 36/52 (69.2 %). The median follow-up time for ovarian angiosarcoma was 7 months (IQR1-IQR3:2-13.5 months). 24 (48 %) of the 50 patients with available survival data were alive and 26/50 (52 %) were dead of disease. Survival analyses (KM curves) revealed that the presence of necrosis (log-rank test; p = 0.05) and absence of spindle-shaped cells (log rank test; p = 0.04) on histopathology were associated with worse outcomes, while treatment with combined chemotherapy and surgical excision was associated with better survival (P < 0.001) therefore, prompt diagnosis and early treatment with combined chemotherapy and surgical excision can prolong survival in OA.
Collapse
Affiliation(s)
- Shafi Rehman
- Department of Histopathology, Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Pakistan.
| | | | - Amisha Silwal
- Cagayan State University College of Medicine, Philippines
| | - B R Sumie
- KMCH Medical College Hospital, India
| | - Safdar Mohamed
- Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova
| | | | - Meghana Maddi
- Kamineni Academy of Medical Sciences and Research Center, Hyderabad, India
| | - Linh Huynh
- Kansas College of Osteopathic Medicine, United States of America
| | | | | | | |
Collapse
|
2
|
Johnson AM, Argenta PA. Angiosarcoma of the ovary treated with polyadenosine ribose polymerase Inhibition, a case report and review of the literature. Gynecol Oncol Rep 2023; 49:101264. [PMID: 37680504 PMCID: PMC10481173 DOI: 10.1016/j.gore.2023.101264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/16/2023] [Accepted: 08/20/2023] [Indexed: 09/09/2023] Open
Abstract
âąPrimary angiosarcoma of the ovary historically has no standard treatment due to its rarity, and outcomes have been variable.âąOlaparib may represent a viable treatment option for primary angiosarcoma of the ovary with a somatic BRCA mutation.âąNext-generation sequencing may play an important component in treatment of very rare cancers to guide new or uncommon therapies.
Collapse
Affiliation(s)
- Andrea M Johnson
- Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, United States
| | - Peter A Argenta
- Division Gynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN 55455, United States
| |
Collapse
|
3
|
Zhou Y, Sun YW, Liu XY, Shen DH. Primary ovarian angiosarcoma: Two case reports and review of literature. World J Clin Cases 2023; 11:5122-5128. [PMID: 37583851 PMCID: PMC10424018 DOI: 10.12998/wjcc.v11.i21.5122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2023] [Revised: 06/05/2023] [Accepted: 06/27/2023] [Indexed: 07/26/2023] Open
Abstract
BACKGROUND Angiosarcoma (AS) is a rare and highly aggressive soft tissue disease that most commonly arises in deep soft tissues. There are only a few reported cases of AS involving the ovary and even fewer reports of the underlying molecular abnormalities. Here, we briefly review two cases of primary ovarian AS (oAS) with specific molecular events and immune checkpoints. The clinical features and prognosis of the disease, diagnosis, differential diagnosis, and new treatment approaches are discussed based on a literature review. CASE SUMMARY Case 1: A 51-year-old female patient was admitted with right lower limb pain for 5 mo, and lower abdominal pain with hematuria for 1 mo. Partial removal of rectus abdominis muscle and fascia, partial hysterectomy, bilateral salpingo-oophorectomy, and inguinal and pelvic lymphadenectomy were performed. Pathology revealed primary oAS. Fluorescence in situ hybridization revealed c-MYC gene amplification. MESNA + ADM + IFO + DTIC (MAID) regimen was administered, but stable disease was achieved. The patient died 1 mo later. Case 2: A 41-year-old female patient presented with fatigue, nausea, decreased appetite, and diffuse abdominal pain. On physical examination, the abdomen was distended and a complex cystic mass was palpable in the right pelvic cavity. Pathology revealed primary oAS. MAID chemotherapy was administered and programmed death ligand 1 (PD-L1) staining was performed on the tumor samples. The patient benefited from anti-PD-1 immunotherapy and is alive without any evidence of disease 27 mo off therapy in follow-up. CONCLUSION Long-term survival benefit for primary oAS can be achieved by alternative therapeutic strategies using pathological indicators to inform treatment.
Collapse
Affiliation(s)
- Ying Zhou
- Department of Pathology, Peking University Peopleâs Hospital, Beijing 100044, China
| | - Yi-Wen Sun
- Department of Pathology, Peking University Peopleâs Hospital, Beijing 100044, China
| | - Xiao-Yang Liu
- Department of Pathology, Peking University Peopleâs Hospital, Beijing 100044, China
| | - Dan-Hua Shen
- Department of Pathology, Peking University Peopleâs Hospital, Beijing 100044, China
| |
Collapse
|
4
|
Peng X, Duan Z, Yin H, Dai F, Liu H. Ovarian epithelioid angiosarcoma complicating pregnancy: a case report and review of the literature. J Int Med Res 2021; 49:3000605211019641. [PMID: 34039070 PMCID: PMC8168035 DOI: 10.1177/03000605211019641] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Epithelioid angiosarcoma is a rare and highly aggressive soft tissue angiosarcoma most commonly arising in the deep soft tissues. Given that abundant vascular cavities anastomose with each other, most angiosarcomas prone to metastasis recur quickly, and the overall prognosis is poor. We report a 25-year-old woman at 24 weeksâ gestation who presented with a 1-month history of abdominal distension. Ultrasonography suggested a mass in the right adnexa, and she underwent two operations owing to uncontrolled intraperitoneal bleeding with progressive anemia. The right ovarian tumor and right adnexa were removed successively. Biopsy yielded a diagnosis of primary epithelioid angiosarcoma with mature cystic teratoma. The patient died from uncontrolled progressive bleeding 1 week after the second operation. This case revealed that epithelial angiosarcoma is a highly malignant endothelial cell tumor. The results of surgery and chemoradiotherapy tend to be poor, and the recurrence rate is high. The purpose of this study is to raise clinical awareness of epithelial angiosarcoma and its adverse events and to provide new ideas for the treatment of these adverse events. Immunohistochemical staining of pathological specimens can facilitate diagnosis. Pregnancy with malignant tumors may lead to rapid disease progression, extensive lesions, and a poor prognosis.
Collapse
Affiliation(s)
- Xiaotong Peng
- Department of Gynecology and Obstetrics, Xiangya Hospital Central South University, Changsha, Hunan, China
| | - Zhi Duan
- Department of Pathology, The First Hospital of Changsha City, Changsha, Hunan, China
| | - Hongling Yin
- Department of Pathology, Xiangya Hospital Central South University, Changsha, Hunan, China
| | - Furong Dai
- Department of Gynecology and Obstetrics, Xiangya Hospital Central South University, Changsha, Hunan, China
| | - Huining Liu
- Department of Gynecology and Obstetrics, Xiangya Hospital Central South University, Changsha, Hunan, China
| |
Collapse
|
5
|
Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor. J Ovarian Res 2021; 14:21. [PMID: 33509230 PMCID: PMC7844967 DOI: 10.1186/s13048-021-00771-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Accepted: 01/20/2021] [Indexed: 01/21/2023] Open
Abstract
The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left ovary mass. Grossly, the cut surface of the tumor was solid and gray-white with intermediate texture. Some areas were spongy and atropurpureus with a soft texture. Microscopically, the tumor cells were arranged into a variety of different structures with visible hemorrhage. Immunochemically, the tumor cells were positive for CD31, ERG, Fli1, D2-40 and vimentin in a strong and diffused manner. CD34 stain showed focal positivity. Epithelial markers (e.g. CK, CK7, CK8/18 and PAX8) were all negative. Negative immunostaining for SMA, S-100, P53 and calretinin also were detected. The proliferative index (Ki-67) was approximately 40%. After surgery, the patient was treated with radiotherapy, targeted therapy and immunotherapy. In the 9-month follow-up, the patient was survival without evidence of disease. The diagnosis of ovarian angiosarcoma required the careful observation of morphology and the reasonable application of immunohistochemistry. Targeted therapy and immunotherapy are the potential directions for the treatment of angiosarcoma.
Collapse
|
6
|
van der Hel O, Timmermans M, van Altena A, Kruitwagen R, Slangen B, Sonke G, van de Vijver K, van der Aa M. Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989â2015. Eur J Cancer 2019; 118:97-104. [DOI: 10.1016/j.ejca.2019.06.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Revised: 06/07/2019] [Accepted: 06/12/2019] [Indexed: 02/06/2023]
|
7
|
Pariury H, Golden C, Huh WW, Cham E, Chung T, Hayes-Jordan A. Pediatric ovarian angiosarcoma treated with systemic chemotherapy and cytoreductive surgery with heated intraperitoneal chemotherapy: Case report and review of therapy. Pediatr Blood Cancer 2019; 66:e27753. [PMID: 30977252 DOI: 10.1002/pbc.27753] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/07/2018] [Revised: 02/22/2019] [Accepted: 02/23/2019] [Indexed: 12/14/2022]
Abstract
Ovarian angiosarcoma is a rare and aggressive vascular tumor, which has a 5-year overall survival of less than 30% for patients with nonmetastatic disease and almost certain death within 1 year for those with metastasis. Here, we briefly review historical approaches to therapy and present a long-term survivor in the case of an 11-year-old female with metastatic ovarian angiosarcoma. This is the second reported case to utilize heated intraperitoneal chemotherapy in the treatment of this disease. Our patient is currently alive and well 3 years after initial diagnosis, significantly longer than any reported case of advanced-stage ovarian angiosarcoma.
Collapse
Affiliation(s)
- Holly Pariury
- Department of Hematology-Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, California
| | - Carla Golden
- Department of Hematology-Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, California
| | - Winston W Huh
- Department of Hematology-Oncology, Children's Hospital of Los Angeles, Los Angeles, California
| | - Elaine Cham
- Department of Pathology, UCSF Benioff Children's Hospital Oakland, Oakland, California
| | - Taylor Chung
- Department of Radiology, UCSF Benioff Children's Hospital Oakland, Oakland, California
| | - Andrea Hayes-Jordan
- Department of Pediatric Surgery, University of North Carolina Children's Hospital, Chapel Hill, North Carolina
| |
Collapse
|
8
|
Primary ovarian angiosarcoma in a 12- year -old girl: a case report of an exceptional localization in a context of limited resources country. BMC Clin Pathol 2017; 17:16. [PMID: 28852325 PMCID: PMC5571497 DOI: 10.1186/s12907-017-0056-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Accepted: 08/21/2017] [Indexed: 11/29/2022] Open
Abstract
Background Ovarian sarcomas represent less than 1% of all ovary cancers and usually are frequent in adults. Primary angiosarcomas are exceptional in the ovaries within children. Case presentation We reported a case of primary ovarian angiosarcoma in a 12-year-old girl in a resource-constrained context. Immunohistochemistry study showed the positivity of CD34, CD31, factor VIII, while S100 was negative. The diagnosis of primary non-metastatic angiosarcoma was retained. She was unable to undergo the CWS-2002P chemotherapy since her parents could not afford it. Conclusion This case report described a rare type of a primary ovarian angiosarcoma within a child, diagnosed in a low-income country in a laboratory with limited resources.
Collapse
|
9
|
Yonezawa I, Waki M, Tamura Y, Onoda R, Narushima M, Ishizuka T, Tajima S. Gemcitabine-based regimen for primary ovarian angiosarcoma with MYC amplification. ACTA ACUST UNITED AC 2014; 21:e782-9. [PMID: 25489268 DOI: 10.3747/co.21.2144] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Angiosarcoma is a rare and aggressive type of sarcoma, and primary angiosarcoma of the ovary is extremely rare. We report the case of a 29-year-old woman who was diagnosed with ovarian angiosarcoma and possible bone metastases. We treated this patient with a gemcitabine-based regimen as postoperative adjuvant chemotherapy, after which she achieved at least 7 years of progression-free survival, an extremely long duration given the aggressive features of this tumour. We retrospectively performed immunohistochemical analyses and fluorescence in situ hybridization to make a pathology diagnosis and to investigate the tumour features. MYC amplification and c-Myc protein overexpression were positively detected. It might be possible to correlate the effectiveness of the gemcitabine-based chemotherapeutic regimen with MYC gene amplification and c-Myc protein overexpression.
Collapse
Affiliation(s)
- I Yonezawa
- Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan
| | - M Waki
- Cell Biology and Anatomy, Hamamatsu University School of Medicine, Shizuoka, Japan
| | - Y Tamura
- Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan
| | - R Onoda
- Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan
| | - M Narushima
- Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan
| | - T Ishizuka
- Obstetrics and Gynecology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan
| | - S Tajima
- Pathology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan
| |
Collapse
|
10
|
Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival. Int J Gynecol Cancer 2014; 24:4-12. [PMID: 24257655 DOI: 10.1097/igc.0000000000000020] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
OBJECTIVE Angiosarcomas are aggressive, malignant soft tissue neoplasms of endothelial origin and occur rarely in the female genital tract. There is lack of consensus on risk factors for poor outcome and optimal treatment. To this end, we performed a clinicopathologic review and survival analysis. METHODS We report a case of a woman with an angiosarcoma of the vagina. Published English literature was reviewed for angiosarcomas of the vulva, vagina, uterus, and ovary. Survival was evaluated by using Kaplan-Meier analysis and the effect of clinical and demographic variables on survival by using Cox regression analysis. RESULTS A total of 51 patients were identified with a median age of 47 years (range, 17-87 years). Two of the patients had an angiosarcoma of the vulva; 2 had an angiosarcoma of the vagina; 18 had an angiosarcoma of the uterus, and 29 had an angiosarcoma of the ovary. Five-year overall survival was 27% (SE, 8%). Most patients presented with locoregional disease, having surgery as their primary intervention. Overall, adjuvant therapy significantly improved survival (hazards ratio, 0.17; 95% confidence interval, 0.05-0.59; adjusted for age and tumor size). Adjuvant treatment consisted of radiotherapy for angiosarcomas of the vulva, vagina, and uterus and chemotherapy for ovarian angiosarcomas. Subgroup analysis of the female genital tract site was hampered by the small number of cases. CONCLUSIONS This review supports the use of surgical and adjuvant radiotherapy for angiosarcomas of the vulva, vagina, and uterus. Cytoreductive surgery and adjuvant chemotherapy remain the primary treatment of angiosarcomas of the ovary.
Collapse
|
11
|
Guseh SH, Bradford LS, Hariri LP, Schorge JO. Ovarian angiosarcoma: Extended survival following optimal cytoreductive surgery and adjuvant chemotherapy. GYNECOLOGIC ONCOLOGY CASE REPORTS 2012; 4:23-5. [PMID: 24371666 DOI: 10.1016/j.gynor.2012.12.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/13/2012] [Accepted: 12/08/2012] [Indexed: 11/29/2022]
Affiliation(s)
- Stephanie H Guseh
- Department of Obstetrics and Gynecology, Massachusetts General Hospital, USA ; Department of Obstetrics, Gynecology and Reproductive Biology, Brigham & Women's Hospital, USA
| | - Leslie S Bradford
- Division of Gynecologic Oncology, Massachusetts General Hospital, USA
| | - Lida P Hariri
- Department of Pathology, Massachusetts General Hospital, USA
| | - John O Schorge
- Division of Gynecologic Oncology, Massachusetts General Hospital, USA
| |
Collapse
|
12
|
Zacarias Föhrding L, Macher A, Braunstein S, Knoefel WT, Topp SA. Small intestine bleeding due to multifocal angiosarcoma. World J Gastroenterol 2012; 18:6494-6500. [PMID: 23197897 PMCID: PMC3508646 DOI: 10.3748/wjg.v18.i44.6494] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2012] [Accepted: 09/28/2012] [Indexed: 02/06/2023] Open
Abstract
We report a case of an 84-year-old male patient with primary small intestinal angiosarcoma. The patient initially presented with anemia and melena. Consecutive endoscopy revealed no signs of upper or lower active gastrointestinal bleeding. The patient had been diagnosed 3 years previously with an aortic dilation, which was treated with a stent. Computed tomography suggested an aorto-intestinal fistula as the cause of the intestinal bleeding, leading to operative stent explantation and aortic replacement. However, an aorto-intestinal fistula was not found, and the intestinal bleeding did not arrest postoperatively. The constant need for blood transfusions made an exploratory laparotomy imperative, which showed multiple bleeding sites, predominately in the jejunal wall. A distal loop jejunostomy was conducted to contain the small intestinal bleeding and a segmental resection for histological evaluation was performed. The histological analysis revealed a less-differentiated tumor with characteristic CD31, cytokeratin, and vimentin expression, which led to the diagnosis of small intestinal angiosarcoma. Consequently, the infiltrated part of the jejunum was successfully resected in a subsequent operation, and adjuvant chemotherapy with paclitaxel was planned. Angiosarcoma of the small intestine is an extremely rare malignant neoplasm that presents with bleeding and high mortality. Early diagnosis and treatment are essential to improve outcome. A small intestinal angiosarcoma is a challenging diagnosis to make because of its rarity, nonspecific symptoms of altered intestinal function, nonspecific abdominal pain, severe melena, and acute abdominal signs. Therefore, a quick clinical and histological diagnosis and decisive measures including surgery and adjuvant chemotherapy should be the aim.
Collapse
|
13
|
Therapy of radiation-induced angiosarcoma of the breast in an elderly patient. Arch Gynecol Obstet 2012; 287:827-31. [PMID: 23008109 DOI: 10.1007/s00404-012-2555-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2012] [Accepted: 09/04/2012] [Indexed: 10/27/2022]
|
14
|
Pelvic Angiosarcoma Occurring in a Postmenopausal Female: Case Report and Review of the Literature. Pathol Oncol Res 2012; 19:135-9. [DOI: 10.1007/s12253-012-9540-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/21/2011] [Accepted: 05/17/2012] [Indexed: 01/18/2023]
|
15
|
Sarcoma of vulva, vagina and ovary. Best Pract Res Clin Obstet Gynaecol 2011; 25:797-801. [DOI: 10.1016/j.bpobgyn.2011.07.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2011] [Accepted: 07/08/2011] [Indexed: 11/19/2022]
|
16
|
IljazoviÄ E, TomiÄ S, MustedanagiÄ-MujanoviÄ J, KarasalihoviÄ Z, Kuljanin M, FatuĆĄiÄ Z, KonjiÄ E, HusariÄ E, LatifagiÄ A, ArnautaliÄ L. Angiosarcoma of the ovary in an 11 year old girl: case report and review of the literature. Bosn J Basic Med Sci 2011; 11:132-6. [PMID: 21619563 DOI: 10.17305/bjbms.2011.2599] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Sarcomas of the female genital tract in general are rare and ovarian sarcomas comprise less than 1% of ovarian malignancies. In the literature there are 15 reported angiosarcomas of patients 21 year old and younger with no one originated in the ovary. We report a case of ovarian angiosarcoma in an 11 year old girl, presented with left side hip pain. MRI of abdomen and pelvis confirmed expansive solid and cystic mass occupied both ovaries. Imunohistochemistry staining was performed, CD34, Factor VIII, CD31, in order to confirm the diagnosis. Final diagnosis was angiosarcoma. The patient received 6 cycles of chemotherapy, according to the CWS-2002P protocol. 8 months after the diagnosis was established, there were no signs of any tumors according to the ultrasound, CT scan, and MRI. Although, extremely rare, angiosarcoma can also affect children and this diagnosis should be considered carefully in tumor with rich vascular network, necrosis and brisk mitotic activity.
Collapse
Affiliation(s)
- Ermina IljazoviÄ
- Department of Pathology, University Clinical Center Tuzla, Bosnia and Herzegovina.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
BösmĂŒller H, Gruber C, Haitchi-Petnehazy S, Wagner D, Webersinke G, Hauptmann S. Primary angiosarcoma of the ovary with prominent fibrosis of the ovarian stroma. Case report of an 81-year old patient. Diagn Pathol 2011; 6:65. [PMID: 21752298 PMCID: PMC3143917 DOI: 10.1186/1746-1596-6-65] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2011] [Accepted: 07/14/2011] [Indexed: 11/24/2022] Open
Abstract
Primary angiosarcoma of the ovary (AS) is a rare entity with only 31 reported cases. The majority are pure angiosarcomas, the remainder are associated either with teratomas or conventional epithelial tumors. More than 50% of ovarian AS are disseminated at the time of diagnosis, the minority is detected in stage I. The prognosis of ovarian angiosarcoma in general is poor. Most reports refer to younger individuals, aged from 7 to 46 years, and only 2 case reports could be found for patients older than 64 years. Here we present a very unusual case of angiosarcoma in a 81-year-old patient.
Collapse
Affiliation(s)
- Hans BösmĂŒller
- Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Austria.
| | | | | | | | | | | |
Collapse
|
18
|
Aragon L, Terreros D, Ho H, Greenberg H, Kupesic Plavsic S. Angiosarcoma of the ovary arising in a mucinous cystadenoma. JOURNAL OF CLINICAL ULTRASOUND : JCU 2011; 39:351-355. [PMID: 21500201 DOI: 10.1002/jcu.20821] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2010] [Accepted: 02/22/2011] [Indexed: 05/30/2023]
Abstract
We report the case of a 39-year-old woman who presented with a pelvic mass extending into the upper abdomen. Transabdominal sonography revealed a complex left adnexal mass. Color Doppler imaging and spectral Doppler analysis showed increased vascularity with low impedance blood flow signals, suggestive of neovascularization. The patient underwent a laparotomy and a 56-kg predominantly cystic tumor was removed from the left adnexal region. The patient died 3 months later with pulmonary metastases and massive pulmonary hemorrhage. Postmortem resampling of the ovarian tumor initially diagnosed as mucinous cystadenoma showed nodular areas of malignant pleomorphic cells consistent with angiosarcoma.
Collapse
Affiliation(s)
- Lorenzo Aragon
- Department of Family and Community Medicine, Paul L. Foster School of Medicine, TX Tech University Health Sciences Center, 9849 Kenworthy, El Paso, TX 79924, USA
| | | | | | | | | |
Collapse
|
19
|
Serrano C, GarcĂa Ă, Brana I, PĂ©rez-Benavente A, Oaknin A. Angiosarcoma of the Ovary: Is It Always a Lethal Disease? J Clin Oncol 2010; 28:e675-7. [DOI: 10.1200/jco.2010.30.0830] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | - Irene Brana
- Vall d'Hebron University Hospital, Barcelona, Spain
| | | | - Ana Oaknin
- Vall d'Hebron University Hospital, Barcelona, Spain
| |
Collapse
|